About
Guided by our values, we are an impact-driven organization that improves care in every setting – one product, one partner, one patient at a time.
Guided by our values, we are an impact-driven organization that improves care in every setting – one product, one partner, one patient at a time.
Through our core commitments, we are leveraging our scale for the greater good, such as serving the needs of our stakeholders, donating back to our communities, protecting our planet, working with policymakers, and more.
Every year, we publish updates to our commitments through our Impact Report.
Download Our Impact ReportOur businesses bring together leading technologies, innovative solutions and hands-on expertise to support the entire healthcare ecosystem.
We distribute pharmaceuticals and medical supplies to healthcare settings across North America, from pharmacies and hospitals to doctors’ offices and clinics.
We help to ensure the financial wellbeing of pharmacies and health systems and support a stable work environment for their employees.
We provide research, insights, technologies and other support to help address challenges in cancer and specialty care.
We provide a suite of solutions designed to address access, affordability and adherence challenges by bridging the gaps between biopharma companies, pharmacies, providers, and payers to help patients get on and stay on their medications.
We offer solutions that enable employers, payers, health-plan brokers and government agencies to provide lower-cost options for prescription medications and therapies.
We help to ensure the financial wellbeing of pharmacies and health systems and support a stable work environment for their employees.
Every year, we publish updates to our commitments through our Impact Report.
Download Our Impact Report
How PRISM Vision Group helps streamline operations, enhance clinical care and support ophthalmology and retina practices.
Read Time
3 minutes
Key Points
PRISM Vision Group (PRISM) is a physician-led organization focused on supporting community-based ophthalmology and retina practices. Backed by McKesson, PRISM combines clinical scale with centralized infrastructure to address operational, regulatory and workforce challenges that affect eye care today. The following five points explain how PRISM operates and why its centralized support model is relevant to ophthalmology and retina practices.
Prior authorization remains a major source of workflow friction for ophthalmology and retina practices. PRISM operates a centralized prior authorization model designed to streamline and optimize this work. Rather than managing approvals at the individual office level, practices can rely on shared services that standardize processes, manage payer requirements and track submissions.
For physicians and administrators, this structure is intended to reduce delays in care, limit staff burnout, and create more predictable revenue cycles.
PRISM uses unified EMR systems across its network. This standardization enables the use of virtual scribe services and supports consistent documentation practices across locations.
Virtual scribes can assist clinicians with real-time documentation, helping reduce after-hours charting and variability in records. From an operational standpoint, standardized EMR use also simplifies onboarding, training, compliance reporting and data analysis. These systems are tangible assets that illustrate how PRISM scales efficiently while maintaining clinical consistency.
PRISM includes more than 200 clinicians across over 100 offices and eight ambulatory surgery centers. This scale supports shared clinical expertise, peer collaboration and access to subspecialty resources that may be difficult for independent practices to sustain alone.
For physicians, it creates opportunities for collaboration without requiring them to relinquish local practice identity.
With McKesson’s support, PRISM aligns clinical operations with broader research, data and infrastructure capabilities. PRISM maintains active research and teaching programs, which can benefit from our experience in data interoperability, compliance and healthcare operations, as well as access to leading perspectives on the adoption of AI and emerging technologies.
This alignment is relevant to physicians interested in clinical research and innovation, as well as to administrators responsible for navigating regulatory complexity and determining how to adopt new technologies effectively.
PRISM supports practice growth by helping ophthalmology and retina practices spend less time on administrative complexity and more time on patient care. Through centralized services such as credentialing, revenue cycle management, billing, payer contracting, compliance, IT integration and practice administration, PRISM provides the operational infrastructure needed to help practices run more efficiently and scale sustainably.
While payer confidence in the science is growing, reimbursement complexity, data gaps and system misalignment remain barriers to broader cell and gene therapy access.
A 2026 survey of 100 senior-level life sciences professionals suggests the next opportunity in oncology real-world data is not simply more data, but linked data that is trusted, timely and ready to support stronger clinical and commercial decisions.
Community oncology is expanding access to advanced cancer care by bringing precision medicine, clinical research and technology-enabled support closer to where patients live and receive ongoing treatment.
Explore how The US Oncology Network is shaping the future of community oncology through collaboration, innovation and partnership.
Insights from two McKesson-led discussions on collaboration and reimbursement at Asembia’s AXS26 Summit.
McKesson’s GPOs empower independent healthcare providers to access differentiated contract pricing and terms, navigate rising drug costs and sustain community-based care.
Leveraging data from the largest community oncology networks, we look at factors increasing colorectal cancer in younger patients.
How treatment centers can access CGTs through two different channel strategies — Buy-and-Bill and Specialty Pharmacy.
Discover how coordinated rare disease care simplifies complex workflows, supports providers with specialty pharmacy services, and improves the patient journey.
McKesson Clinical Research Services (CRS) provides integrated logistics and operational support designed to meet the complexities of clinical trials.